يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Cannon CP"', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المصدر: urn:ISSN:0272-6386 ; urn:ISSN:1523-6838 ; American Journal of Kidney Diseases, 82, 1, 84-96.e1

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: urn:ISSN:1046-6673 ; urn:ISSN:1533-3450 ; Journal of the American Society of Nephrology, 31, 5, 1128-1139

    وصف الملف: application/pdf

  5. 5
    دورية أكاديمية

    المصدر: urn:ISSN:1555-9041 ; urn:ISSN:1555-905X ; Clinical Journal of the American Society of Nephrology, 15, 12, 1705-1714

    وصف الملف: application/pdf

  6. 6
  7. 7

    المصدر: Bhatt, D L, Szarek, M, Pitt, B, Cannon, C P, Leiter, L A, McGuire, D K, Lewis, J B, Riddle, M C, Inzucchi, S E, Kosiborod, M N, Cherney, D Z I, Dwyer, J P, Scirica, B M, Bailey, C J, Díaz, R, Ray, K K, Udell, J A, Lopes, R D, Lapuerta, P, Steg, P G & SCORED Investigators 2021, ' Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease ', The New England Journal of Medicine, vol. 384, no. 2, pp. 129-139 . https://doi.org/10.1056/NEJMoa2030186Test
    NEW ENGLAND JOURNAL OF MEDICINE
    r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
    instname

    مصطلحات موضوعية: Male, SAXAGLIPTIN, 030204 cardiovascular system & hematology, Saxagliptin, MELLITUS, chemistry.chemical_compound, 0302 clinical medicine, Settore MED/13, Glycosides, 030212 general & internal medicine, 11 Medical and Health Sciences, RISK, SGLT2 INHIBITOR, OUTCOMES, Kidney, EMPAGLIFLOZIN, General Medicine, Middle Aged, Hospitalization, medicine.anatomical_structure, Cardiovascular Diseases, HEART-FAILURE, Diarrhea/chemically induced, Female, OUTPATIENTS, Life Sciences & Biomedicine, Diarrhea, medicine.medical_specialty, SCORED Investigators, Mycoses/etiology, Diabetic ketoacidosis, Renal Insufficiency, Chronic/complications, Glycosides/adverse effects, Diabetic Ketoacidosis, 03 medical and health sciences, Medicine, General & Internal, Sodium-Glucose Transporter 1, Double-Blind Method, General & Internal Medicine, Internal medicine, Diabetes mellitus, medicine, Empagliflozin, Humans, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Hospitalization/statistics & numerical data, Science & Technology, Diabetic Ketoacidosis/chemically induced, urogenital system, business.industry, MORTALITY, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, medicine.disease, CARDIOVASCULAR EVENT RATES, Clinical trial, Mycoses, chemistry, Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 1/antagonists & inhibitors, Heart failure, business, Kidney disease

    وصف الملف: application/pdf